IDH2 and central nervous system cancer: An analysis of EGFR amplification and IDH mutation status revealed that IDH mutated glioma showed fewer copies of EGFR using FISH (Figure 3a) and EPIC (Figure 3b) without this being statistically significant (p > 0.05, Student’s t-test).